Karuna Therapeutics, Inc. Operating Cash Flow
Karuna Therapeutics, Inc. reported Operating Cash Flow of -$385.82 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-02-22
- Karuna Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$111.06M.
- Karuna Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$110.00M.
- Karuna Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$64.13M.
- Karuna Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$100.63M.
- Karuna Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$385.82M.
- Karuna Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$228.01M.
- Karuna Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$100.88M.
- Karuna Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$69.86M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$111.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$221.06M derived: sum of 2 quarters · filed 2024-02-22 | -$285.19M derived: sum of 3 quarters · filed 2024-02-22 | -$385.82M 10-K · filed 2024-02-22 |
| 2023-09-30 | -$110.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$174.13M derived: sum of 2 quarters · filed 2023-11-02 | -$274.76M 10-Q · filed 2023-11-02 | -$353.52M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-06-30 | -$64.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$164.76M 10-Q · filed 2023-08-03 | -$243.52M derived: sum of 3 quarters · filed 2024-02-22 | -$303.47M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-03-31 | -$100.63M 10-Q · filed 2023-05-04 | -$179.39M derived: sum of 2 quarters · filed 2024-02-22 | -$239.33M derived: sum of 3 quarters · filed 2024-02-22 | -$278.83M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-12-31 | -$78.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$138.70M derived: sum of 2 quarters · filed 2024-02-22 | -$178.20M derived: sum of 3 quarters · filed 2024-02-22 | -$228.01M 10-K · filed 2024-02-22 |
| 2022-09-30 | -$59.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$99.45M derived: sum of 2 quarters · filed 2023-11-02 | -$149.25M 10-Q · filed 2023-11-02 | -$156.25M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$39.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$89.30M 10-Q · filed 2023-08-03 | -$96.30M derived: sum of 3 quarters · filed 2024-02-22 | -$140.11M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$49.80M 10-Q · filed 2023-05-04 | -$56.80M derived: sum of 2 quarters · filed 2024-02-22 | -$100.61M derived: sum of 3 quarters · filed 2024-02-22 | -$129.50M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$50.81M derived: sum of 2 quarters · filed 2024-02-22 | -$79.70M derived: sum of 3 quarters · filed 2024-02-22 | -$100.88M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$43.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$72.70M derived: sum of 2 quarters · filed 2022-11-03 | -$93.88M 10-Q · filed 2022-11-03 | -$116.83M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$28.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$50.07M 10-Q · filed 2022-08-08 | -$73.02M derived: sum of 3 quarters · filed 2023-02-23 | -$95.80M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$21.18M 10-Q · filed 2022-05-05 | -$44.12M derived: sum of 2 quarters · filed 2023-02-23 | -$66.91M derived: sum of 3 quarters · filed 2023-02-23 | -$82.69M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$22.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$45.73M derived: sum of 2 quarters · filed 2023-02-23 | -$61.52M derived: sum of 3 quarters · filed 2023-02-23 | -$69.86M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$22.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$38.57M derived: sum of 2 quarters · filed 2021-11-04 | -$46.91M 10-Q · filed 2021-11-04 | -$53.73M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$15.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$24.13M 10-Q · filed 2021-08-05 | -$30.95M derived: sum of 3 quarters · filed 2022-02-24 | -$39.37M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$8.34M 10-Q · filed 2021-05-06 | -$15.16M derived: sum of 2 quarters · filed 2022-02-24 | -$23.58M derived: sum of 3 quarters · filed 2022-02-24 | -$33.15M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$15.24M derived: sum of 2 quarters · filed 2022-02-24 | -$24.81M derived: sum of 3 quarters · filed 2022-02-24 | -$30.92M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$8.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$17.99M derived: sum of 2 quarters · filed 2020-11-05 | -$24.10M 10-Q · filed 2020-11-05 | -$30.97M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$9.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$15.69M 10-Q · filed 2020-08-05 | -$22.55M derived: sum of 3 quarters · filed 2021-02-25 | -$24.68M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$6.11M 10-Q · filed 2020-05-07 | -$12.98M derived: sum of 2 quarters · filed 2021-02-25 | -$15.11M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2018-12-31 | -$6.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$8.99M derived: sum of 2 quarters · filed 2021-02-25 | -$15.38M 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$8.51M 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -$6.38M 10-Q · filed 2019-08-08 |